Abstract
AbstractSynthetic biology has spawned a debate about how society and the international community should go about policy‐making, especially given the potential for both transformative benefits and existential threats. One of the significant contributions of “The Ethics of Synthetic Biology: Next Steps and Prior Questions,” by Kaebnick, Gusmano, and Murray, is its exploration of the difficulties of developing policy that appropriately addresses the risks and benefits of synthetic biology. In this comment I want to develop this point further and emphasize how the proper methodology for addressing synthetic biology's ethical and public policy issues are affected by the unpredictable and complex causal webs in synthetic biology (which have analogs in other new and emerging technologies).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
